Titan Medical Inc (TMDI) gains 1.21% for July 21

Equities Staff  |

Titan Medical Inc (NASDAQ: TMDI) shares gained 1.21%, or $0.02 per share, to close Wednesday at $1.68. After opening the day at $1.68, shares of Titan Medical fluctuated between $1.69 and $1.64. 257,056 shares traded hands a decrease from their 30 day average of 458,024. Wednesday's activity brought Titan Medical’s market cap to $184,006,519.

Titan Medical is headquartered in Toronto, Ontario..

About Titan Medical Inc

Titan Medical Inc. is focused on robotic-assisted technologies for application in minimally invasive surgery (“MIS”). Enos, by Titan Medical, is being developed to become the new standard of care in robotic single access surgery, and comprises a surgeon-controlled patient cart that includes a dual-view camera system with 3D and 2D high-definition vision systems and multi-articulating instruments for performing MIS procedures, and a surgeon workstation that provides an ergonomic interface to the MIS procedure performed through the patient cart. With the Enos system, Titan intends to initially pursue gynecologic surgical indications.

Visit Titan Medical Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Titan Medical Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Titan Medical Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content